Abstract
Patients with COVID-19 are at high risk for thrombotic arterial and venous occlusions. Lung histopathology often reveals fibrin-based occlusions in the small blood vessels of patients who succumb to the disease. Antiphospholipid syndrome is an acquired and potentially life-threatening thrombophilia in which patients develop pathogenic autoantibodies targeting phospholipids and phospholipid-binding proteins (aPL antibodies). Read more on Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19…
https://orcid.org/0000-0001-7656-7378
Vademécum
Comentarios recientes